Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumab
暂无分享,去创建一个
A. T. Freeman | M. Lesperance | D. Fenton | D. Ksienski | Z. Poonja | E. Wai | N. Croteau | L. Fiorino | D. Alex | A. Chan | T. Patterson | Melissa Clarkson | S. Irons